Product Usage:
THIS PRODUCT IS INTENDED FOR RESEARCH PURPOSES ONLY.
All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
PT-141
5mgPT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist with high selectivity for MC3R and MC4R. It is the first and only FDA-approved peptide treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women (marketed as Vyleesi). Unlike PDE5 inhibitors that act on blood flow, PT-141 works centrally in the brain through melanocortin pathways to activate sexual desire and arousal. Research demonstrates efficacy in both male and female models, with onset of action within 30-60 minutes and effects lasting 6-72 hours.
Lyophilized powder. Reconstitution Solution (for laboratory use) is required to bring this compound into working concentration prior to analytical testing.
Purchase Option
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist with high selectivity for MC3R and MC4R. It is the first and only FDA-approved peptide treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women (marketed as Vyleesi). Unlike PDE5 inhibitors that act on blood flow, PT-141 works centrally in the brain through melanocortin pathways to activate sexual desire and arousal. Research demonstrates efficacy in both male and female models, with onset of action within 30-60 minutes and effects lasting 6-72 hours.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
Why Choose Us
Premium quality backed by science and transparency.
99%+ Purity
Every batch is independently tested by American third-party laboratories to ensure the highest purity standards in the industry.
cGMP Certified
Manufactured in FDA-audited, cGMP-certified facilities following pharmaceutical-grade quality control protocols.
Certificate of Analysis
Every SKU links to a batch-specific Certificate of Analysis from an independent third-party laboratory documenting purity, identity, and analytical methods.
Frequently Asked Questions
Everything you need to know about PT-141
Still have questions?
Contact our support teamStay
Informed
Receive research updates, new compound announcements, and updated Certificate of Analysis releases.
Research Notifications
Enter your email to receive scientific updates from Axios Peptides.
By subscribing you agree to our Privacy Policy